Inventor · disambiguated record
Zhiqiang Ning
Also filed as: NING ZHIQIANG
6 granted patents·9 pending applications·60 citations·filing 2003–2024
82Inventor score
Files withSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD5LU XIAN-PING3SHENZHEN CHIPSCREEN BIOSCIENCE3AKESO PHARMACEUTICALS INC1CHIPSCREEN BIOSCIENCES LTD1
Top patents by PatentIndex Score
15 records- 0185US7550490B2Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activitySHENZHEN CHIPSCREEN BIOSCIENCE·Filed 2007·Granted Jun 23, 2009·16 cites·19 claims
- 0282US7244751B2Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activitySHENZHEN CHIPSCREEN BIOSCIENCE·Filed 2004·Granted Jul 17, 2007·23 cites·11 claims
- 0381US8211901B2Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitorsLU XIAN-PING·Filed 2010·Granted Jul 3, 2012·11 cites·18 claims
- 0480US10011571B2Preparation method for aromatic heterocyclic compound used as selective JAK3 and/or JAK1 kinase inhibitor and application of aromatic heterocyclic compoundSHENZHEN CHIPSCREEN BIOSCIENCES LTD·Filed 2015·Granted Jul 3, 2018·4 cites·21 claims
- 0566US7268157B2Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activityUNIV TSINGHUA RES INST·Filed 2003·Granted Sep 11, 2007·5 cites·15 claims
- 0662US2025188164A1Pharmaceutical composition comprising anti-ctla4-anti-pd-1 bispecific antibody and chiauranibAKESO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0753US7192970B2Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activityCHIPSCREEN BIOSCIENCES LTD·Filed 2003·Granted Mar 20, 2007·1 cites·16 claims
- 0851US2023117545A1Pharmaceutical composition comprising protein kinase inhibitor and chemotherapeutic drug and use thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 0949US2008051321A1Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activityLU XIAN-PING·Filed 2007·Application pending·0 cites
- 1048US2007142427A1Noncyclic 1,3-Dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activitySHENZHEN CHIPSCREEN BIOSCIENCE·Filed 2007·Application pending·0 cites
- 1148US2021315881A1Combination of histone deacetylase inhibitor and protein kinase inhibitor and pharmaceutical use thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 1247US2021386705A1Application of chiglitazar and related compounds thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 1344US2022184056A1Use of kdm5a gene and atrx geneSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 1442US2022184055A1Chiauranib for treatment of small cell lung cancerSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 1542US2006252708A1Compositions of flavones and long chain fatty acid derivatives isolated from plants and methods related thereto for the control of prostate disordersLU XIAN-PING·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhiqiang Ning files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →